Amgen Inc vs. Sana Biotechnology, Inc. Common Stock
Amgen Inc (AMGN) comes out ahead, leading on 4 of 6 compared factors.
Size & Scale
| AMGN | SANA | |
|---|---|---|
| Market Cap | $206.78 billion | $925.02 million |
| Revenue (TTM) | $38.09 billion | — |
| Net Income (TTM) | $8.74 billion | $-211,822,000 |
AMGN leads on 3 of 3 size & scale factors.
Valuation
| AMGN | SANA | |
|---|---|---|
| P/E Ratio | 23.44 | — |
| Price / Book | 17.69 | 5.98 |
| Price / Sales | 5.43 | — |
SANA leads on 1 of 1 valuation factors.
Profitability
| AMGN | SANA | |
|---|---|---|
| Net Margin | 22.95% | — |
| Return on Equity | 74.80% | -137.04% |
AMGN leads on 1 of 1 profitability factors.
Dividend
| AMGN | SANA | |
|---|---|---|
| Dividend Yield | 2.67% | — |
| Payout Ratio | 62.61 | — |
AMGN and SANA split the dividend factors evenly.
Risk & Sentiment
| AMGN | SANA | |
|---|---|---|
| Short Interest | 1.66% | 0.18% |
SANA leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, SANA overview, SANA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.